ישראל - עברית - Ministry of Health

bristol, myers squibb (israel) limited, israel - ozanimod as hydrochloride - קפסולות - ozanimod as hydrochloride 0.23 mg - ozanimod

ישראל - עברית - Ministry of Health

bristol, myers squibb (israel) limited, israel - ozanimod as hydrochloride - קפסולות - ozanimod as hydrochloride 0.46 mg - ozanimod

ישראל - עברית - Ministry of Health

bristol, myers squibb (israel) limited, israel - ozanimod as hydrochloride - קפסולות - ozanimod as hydrochloride 0.92 mg - ozanimod

ישראל - עברית - Ministry of Health

bristol, myers squibb (israel) limited, israel - luspatercept - אבקה להכנת תמיסה לזריקה - luspatercept 25 mg - luspatercept

ישראל - עברית - Ministry of Health

bristol, myers squibb (israel) limited, israel - luspatercept - אבקה להכנת תמיסה לזריקה - luspatercept 75 mg - luspatercept

ישראל - עברית - Ministry of Health

bristol, myers squibb (israel) limited, israel - azacitidine - טבליות מצופות פילם - azacitidine 200 mg - azacitidine

ישראל - עברית - Ministry of Health

bristol, myers squibb (israel) limited, israel - azacitidine - טבליות מצופות פילם - azacitidine 300 mg - azacitidine

ישראל - עברית - Ministry of Health

neopharm ltd - azacitidine - lyophilized powder for suspension for injection - azacitidine 100 mg/vial - azacitidine - azacitidine - for the treatment of patients with the following myelodysplastic syndromes subtypes: refractory anemia or refractory anemia with ringed sideroblasts ( if accompanied by neutropenia or thrombocytopenia or requiring transfusions),refractory anaemia with excess blasts, refractory anaemia with excess blasts in transformation, and chronic myelomonocytic leukaema.

ישראל - עברית - Ministry of Health

neopharm ltd - azacitidine 100 mg - lyophilized powder for suspension for injection - azacitidine - for the treatment of patients with the following myelodysplastic syndromes subtypes: refractory anemia or refractory anemia with ringed sideroblasts ( if accompanied by neutropenia or thrombocytopenia or requiring transfusions),refractory anaemia with excess blasts, refractory anaemia with excess blasts in transformation, and chronic myelomonocytic leukaema.

ישראל - עברית - Ministry of Health

neopharm scientific ltd - romidepsin - אבקה ומדלל להכנת תמיסה להזרקה - romidepsin 10 mg/vial - romidepsin - romidepsin - • treatment of cutaneous t-cell lymphoma (ctcl) in patients who have received at least one prior systemic therapy.• treatment of peripheral t-cell lymphoma (ptcl) in patients who have received at least one prior therapy.